Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy

C. M Contreras, E. A Akbay, T. D Gallardo, J. M Haynie, S Sharma, O Tagao, N Bardeesy, M Takahashi, J Settleman, K. K Wong and D. H. Castrillon

Disease Models and Mechanisms 3 ( 3-4 ): 181 - 193 , 2010